Coverage / LON:ANCR / Trade Card

LON:ANCR

Animalcare Group Plc

OPPORTUNISTIC BUY 2026-08-01 Updated today 334.00p Healthcare - Drug Manufacturers - Specialty & GenericREDUCE ZONE
53

Position levels

Currenttoday
334.00p
Buy <=wait / entry
270.00p
Trim >=take some off
330.00p
Thesis breakThe thesis is invalidated by the Charterhouse recommended acquisition failing to...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case18%100 / 10018.0
Base case52%62 / 10032.2
Bear case30%10 / 1003.0
Weighted conviction53 / 100 - OPPORTUNISTIC BUY

Top risks

  • Recommended acquisition by Charterhouse Capital Partners LLP
  • 20% revenue growth to GBP 89.1m and 52.6% underlying EBITDA growth to GBP 17.7m in H2 2025 driven by Randlab acquisition
  • High P/E ratio of 45.68 with neutral investment thesis
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.